Pay-to-participate clinical research: Implications for ethics and study design Stručna događanja u Hrvatskoj

Pay-to-participate clinical research: Implications for ethics and study design

 

"Pay-to-participate clinical research: Implications for ethics and study design"

 

 

15. studenoga 2018.,

Hrvatsko farmaceutsko društvo, Masarykova 2/II, Zagreb

17:00-18:30h

 

 

 

Organizatori:

Medicinski fakultet Sveučilišta u Zagrebu

Međunarodna mreža Navigating Knowledge Landscapes

Hrvatsko farmaceutsko društvo - Radna skupina za sigurnosne informacije i klinička ispitivanja (pri Sekciji za farmaceutsku regulativu)

Farmaceutsko - biokemijski fakultet Sveučilišta u Zagrebu

 

 

 

 

PROGRAM  |

 

 

17:00 - 17:10

UVOD

Prof. dr. sc. Srećko Gajović, dr. med.

Sveučilište u Zagrebu, Medicinski fakultet, Hrvatski institut za istraživanje mozga, osnivač i dopredsjednik međunarodne mreže Navigating Knowledge Landscapes

 

 

17:10 - 17:45

PAY-TO-PARTICIPATE CLINICAL RESEARCH: IMPLICATIONS FOR ETHICS AND STUDY DESIGN

Prof. dr. sc. Douglas Sipp

RIKEN Center for Biosystems Dynamics Research

Keio University School of Medicine

 

 

17:45 - 18:15

PANEL:

  • Prof. dr. sc. Douglas Sipp (Riken Center for Biosystems Dynamics Research)
  • Prof. dr. sc. Srećko Gajović (Medicinski fakultet Sveučilišta u Zagrebu, Hrvatski institut za istraživanje mozga, osnivač i dopredsjednik međunarodne mreže Navigating Knowledge Landscapes)
  • Izv. prof. dr. sc. Donatella Verbanac (predsjednica Povjerenstva za etičnost eksperimentalnog rada pri Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu)

 

 

18:15 - 18:30

Rasprava i zaključak

 

 

 

 

PRIJAVA SUDJELOVANJE  |

Sudjelovanje je besplatno, ali je potrebno prijaviti svoj dolazak,

Prijave za sudjelovanje se primaju u Hrvatskom farmaceutskom društvu do popunjenosti kapaciteta dvorane:

telefonski: 01/48 72 849

mailom: office1@farmaceut.org

 

 

 

 

Prof. dr. sc. Douglas Sipp

RIKEN Center for Biosystems Dynamics Research

Keio University School of Medicine

 

 

SAŽETAK:
Pay-to-participate clinical research: Implications for ethics and study design
Kliničke studije po sistemu “Plati i budi uključen”: utjecaj na etiku i dizajn istraživanja

"Beginning in the late 1980s, small numbers of clinical and drug development businesses in the United States began to explore a novel method for funding clinical research studies, which involved charging patients to enroll. This pay-to-participate (PTP) model has gained greater popularity over the past decade due to its widespread adoption by businesses advertising undertested and unapproved “stem cell” interventions. I will discuss the history of this controversial practice, pressures on the validity of results from such trials, and implications for medical ethics, before examining new directions in which the PTP clinical research model appears to be expanding."

 

 

Hrvatsko farmaceutsko društvo Copyright © 2014. All Rights Reserved. Izrada mikroNET d.o.o..